China Universal Asset Management »

Humacyte shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Humacyte (HUMA) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Humacyte

Tip: Access up to 7 years of quarterly data

All positions including Humacyte held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Humacyte by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $125k 23k 5.44
2024-06-30 $67k 14k 4.80
2024-03-31 $62k 20k 3.11
2023-12-31 $34k 12k 2.84
2023-09-30 $7.8k 2.7k 2.93
2023-06-30 $3.9k 1.4k 2.86
2023-03-31 $4.3k 1.4k 3.09
2022-12-31 $2.2k 1.0k 2.11
2022-09-30 $3.0k 965 3.11

More positions owned by China Universal Asset Management

Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Nvidia Corp Common Stock (NVDA)
Amazon.com Common Stock (AMZN)
Meta Platforms Inc-class A Common Stock (META)
Broadcom Common Stock (AVGO)
Vertex Pharmaceuticals Common Stock (VRTX)
Alphabet Inc-cl A Common Stock (GOOGL)
Gilead Sciences Common Stock (GILD)
Amgen Common Stock (AMGN)
Regeneron Pharmaceuticals Common Stock (REGN)
Taiwan Semiconductor-sp Adr (TSM)
Netflix Common Stock (NFLX)
Servicenow Common Stock (NOW)
Visa Inc-class A Shares Common Stock (V)

View all positions for China Universal Asset Management

Top funds holding Humacyte

BlackRock
BlackRock
Vanguard Group
State Street Corporation
Geode Capital Management
Voloridge Investment Management
Nuveen Asset Management
Two Sigma Investments
Susquehanna International
Woodline Partners
Northern Trust
Goldman Sachs Group
Charles Schwab Investment Management
Marshall Wace
Monashee Investment Management

View all funds holding Humacyte